Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
13.18
+0.45 (3.54%)
Nov 21, 2024, 12:50 PM EST - Market open
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $802.05 million as of November 21, 2024. Its market cap has decreased by -13.24% in one year.
Market Cap
802.05M
Enterprise Value
430.37M
1-Year Change
-13.24%
Ranking
Category
Stock Price
$13.18
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has increased from $737.62M to $802.05M, an increase of 8.73%. That is a compound annual growth rate of 1.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 778.32M | -28.25% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytek Biosciences | 789.61M |
| Erasca | 788.81M |
| Autolus Therapeutics | 785.06M |
| Evolus | 784.55M |
| Avid Bioservices | 779.62M |
| Embecta | 777.82M |
| Cronos Group | 775.61M |
| Pacira BioSciences | 772.48M |